Guidelines

• To be added

• To be added

• Radiotherapy Alone for Early-Stage Squamous Cell Carcinoma of the Larynx and Hypopharynx (Int. J. Radiation Oncology Biol. Phys., October 2007)
• Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time (Int. J. Radiation Oncology Biol. Phys., January 2006)
• Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891 (Ann Oncol., October 2012)
• Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets (Semin Radiat Oncol., July 2002)
• Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines (Radiother Oncol., January 2018)
• Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers? (Advances in Radiation Oncology, October-December 2019)
• Target delineation for postoperative treatment of head and neck cancer (Oral Oncol., November 2018)
• Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines (Radiother Oncol., January 2014)

• To be added

Lung cancer staging:

• Rusch et al. The IASLC Lung Cancer Staging Project. A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer. JTO 2009;4(5):568-77.
• Silvestri et al. Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013;143(5)(Suppl):e211S-e250S.
• Detterbeck et al. The Eighth Edition Lung Cancer Stage Classification. Chest 2017;151(1):193-203.

General treatment guidelines:

• https://www.esmo.org/guidelines/lung-and-chest-tumours
• https://www.nccn.org/professionals/physician_gls/
• Postmus et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28 (Supplement 4): iv1-iv21.

Radiation therapy guidelines:

• De Ruysscher et al. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol 2017;124:1-10.
• Nestle et al. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. Radiother Oncol 2018;127:1-5
• Guckenberger et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early-stage non-small cell lung cancer. Radiother Oncol 2017;124:11-17
• Peeters et al. Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: how to use E(B)US-NA information in addition to PET-CT for delineation? Radiother Oncol 2016;120(2):273-8.
• Hanna et al. UK consensus on normal tissue dose constraints for stereotactic radiotherapy SABR dose constraints. Clin. Oncol (R Coll Radiol.) 2018;30(1):5-14
• Milo et al. Delineation of whole heart and substructures in thoracic radiation therapy: national guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups. Radiothérapie Oncol 2020; 150:121-127
• Kong et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442-57
• Feng et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79:10-18
• Duane et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol 2017;122:416-422

• https://www.ilrog.org/guidelines
• https://www.esmo.org/guidelines/haematological-malignancies
• The conundrum of Hodgkin Lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
  Radiother Oncol. 2008 Aug;88(2):202-10.  doi: 10.1016/j.radonc.2008.05.012. Epub 2008 Jun 12.
• Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and  guidelines.
  Radiother Oncol. 2006 Jun;79(3):270-7.  doi: 10.1016/j.radonc.2006.05.015. Epub 2006 Jun 22.

• To be added

• To be added

• To be added

• To be added

• To be added

• Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology, September 2016)
• NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer (The Green Journal, December 2019)

• To be added